Ensol Biosciences Inc. (XKON:140610)
12,450
-320 (-2.51%)
At close: Jun 8, 2026
-54.40% (1Y)
| Market Cap | 168.65B -41.5% |
| Revenue (ttm) | 537.46M +208.9% |
| Net Income | -5.40B |
| EPS | -644.00 |
| Shares Out | 13.55M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7,015 |
| Open | 12,660 |
| Previous Close | 12,770 |
| Day's Range | 11,750 - 12,660 |
| 52-Week Range | 10,350 - 38,800 |
| Beta | 0.59 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |